M. P. Briceño-Casado

Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series

MD Gil-Sierra, M. P. Briceño-Casado, Beatriz De-La-Calle-Riaguas, 2021, European journal of hospital pharmacy : science and practice.

Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison.

MD Gil-Sierra, S. Fénix-Caballero, M. P. Briceño-Casado, 2020, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses

M. Sánchez-Hidalgo, MD Gil-Sierra, S. Fénix-Caballero, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Belantamab mafodotin for relapsed or refractory multiple myeloma

MD Gil-Sierra, M. P. Briceño-Casado, M. Briceño-Casado, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Patient benefit as a goal of humanization.

MD Gil-Sierra, M. P. Briceño-Casado, M. Briceño-Casado, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.